表观遗传药物在焦虑症治疗中的潜在作用。
The Potential Role of Epigenetic Drugs in the Treatment of Anxiety Disorders.
作者信息
Peedicayil Jacob
机构信息
Department of Pharmacology & Clinical Pharmacology, Christian Medical College, Vellore, India.
出版信息
Neuropsychiatr Dis Treat. 2020 Mar 2;16:597-606. doi: 10.2147/NDT.S242040. eCollection 2020.
Abstract
There is increasing evidence that abnormalities in epigenetic mechanisms of gene expression contribute to the pathogenesis of anxiety disorders (ADs). This article discusses the role of epigenetic mechanisms of gene expression in the pathogenesis of ADs. It also discusses the data so far obtained from preclinical and clinical trials on the use of epigenetic drugs for treating ADs. Most drug trials investigating the use of epigenetic drugs for treating ADs have used histone deacetylase inhibitors (HDACi). HDACi are showing favorable results in both preclinical and clinical drug trials for treating ADs. However, at present the mode of action of HDACi in ADs is not clear. More work needs to be done to elucidate how epigenetic dysregulation contributes to the pathogenesis of ADs. More work also needs to be done on the mode of action of HDACi in alleviating the signs and symptoms of ADs.
摘要
越来越多的证据表明，基因表达表观遗传机制的异常与焦虑症（ADs）的发病机制有关。本文讨论了基因表达表观遗传机制在ADs发病机制中的作用。还讨论了目前从使用表观遗传药物治疗ADs的临床前和临床试验中获得的数据。大多数研究使用表观遗传药物治疗ADs的药物试验都使用了组蛋白去乙酰化酶抑制剂（HDACi）。HDACi在治疗ADs的临床前和临床药物试验中均显示出良好效果。然而，目前HDACi在ADs中的作用模式尚不清楚。需要开展更多工作来阐明表观遗传失调如何导致ADs的发病机制。还需要对HDACi缓解ADs体征和症状的作用模式开展更多研究。
相似文献
1
The Potential Role of Epigenetic Drugs in the Treatment of Anxiety Disorders.表观遗传药物在焦虑症治疗中的潜在作用。
Neuropsychiatr Dis Treat. 2020 Mar 2;16:597-606. doi: 10.2147/NDT.S242040. eCollection 2020.
2
The role of epigenetics in anxiety disorders.表观遗传学在焦虑障碍中的作用。
Mol Biol Rep. 2023 Nov;50(11):9625-9636. doi: 10.1007/s11033-023-08787-6. Epub 2023 Oct 7.
3
Epigenetic Drugs for Multiple Sclerosis.用于治疗多发性硬化症的表观遗传药物。
Curr Neuropharmacol. 2016;14(1):3-9. doi: 10.2174/1570159x13666150211001600.
4
Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi.组蛋白去乙酰化酶抑制剂（HDACi）联合疗法治疗癌症：实现HDACi的全部治疗潜力
Front Oncol. 2018 Mar 29;8:92. doi: 10.3389/fonc.2018.00092. eCollection 2018.
5
Histone deacetylase inhibitor pre-treatment enhances the efficacy of DNA-interacting chemotherapeutic drugs in gastric cancer.组蛋白去乙酰化酶抑制剂预处理增强胃癌中 DNA 相互作用化疗药物的疗效。
World J Gastroenterol. 2020 Feb 14;26(6):598-613. doi: 10.3748/wjg.v26.i6.598.
6
Histone Deacetylase Inhibitors (HDACi) Cause the Selective Depletion of Bromodomain Containing Proteins (BCPs).组蛋白去乙酰化酶抑制剂（HDACi）导致含溴结构域蛋白（BCP）的选择性消耗。
Mol Cell Proteomics. 2015 May;14(5):1350-60. doi: 10.1074/mcp.M114.042499. Epub 2015 Mar 9.
7
Repositioning FDA-Approved Drugs in Combination with Epigenetic Drugs to Reprogram Colon Cancer Epigenome.重新定位经美国食品药品监督管理局批准的药物与表观遗传药物联合使用，以重编程结肠癌表观基因组。
Mol Cancer Ther. 2017 Feb;16(2):397-407. doi: 10.1158/1535-7163.MCT-16-0588. Epub 2016 Dec 15.
8
Experience Modulates the Effects of Histone Deacetylase Inhibitors on Gene and Protein Expression in the Hippocampus: Impaired Plasticity in Aging.经验调节组蛋白去乙酰化酶抑制剂对海马体基因和蛋白质表达的影响：衰老过程中可塑性受损。
J Neurosci. 2015 Aug 19;35(33):11729-42. doi: 10.1523/JNEUROSCI.4339-14.2015.
9
Epigenetic therapy of lymphoma using histone deacetylase inhibitors.组蛋白去乙酰化酶抑制剂治疗淋巴瘤的表观遗传学疗法。
Clin Transl Oncol. 2010 Jun;12(6):401-9. doi: 10.1007/s12094-010-0527-3.
10
Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma.神经母细胞瘤中的组蛋白去乙酰化酶和组蛋白去乙酰化酶抑制剂
Front Cell Dev Biol. 2020 Oct 7;8:578770. doi: 10.3389/fcell.2020.578770. eCollection 2020.
引用本文的文献
1
The Role of Long Non-Coding RNA in Anxiety Disorders: A Literature Review.长链非编码RNA在焦虑症中的作用：文献综述
Int J Mol Sci. 2025 May 23;26(11):5042. doi: 10.3390/ijms26115042.
2
Epigenetic markers of disease risk and psychotherapy response in anxiety disorders - a longitudinal analysis of the DNA methylome.焦虑症中疾病风险和心理治疗反应的表观遗传标志物——DNA甲基化组的纵向分析
Mol Psychiatry. 2025 Apr 25. doi: 10.1038/s41380-025-03038-5.
3
Effects of treadmill running on anxiety- and craniofacial pain-like behaviors with histone H3 acetylation in the brain of mice subjected to social defeat stress.跑步机跑步对遭受社会挫败应激的小鼠大脑中焦虑和颅面部疼痛样行为以及组蛋白H3乙酰化的影响。
PLoS One. 2025 Jan 27;20(1):e0318292. doi: 10.1371/journal.pone.0318292. eCollection 2025.
4
approaches in carcinogenicity hazard assessment: case study of pregabalin, a nongenotoxic mouse carcinogen.致癌性危害评估方法：普瑞巴林的案例研究，一种非遗传毒性小鼠致癌物。
Front Toxicol. 2023 Nov 13;5:1234498. doi: 10.3389/ftox.2023.1234498. eCollection 2023.
5
The role of epigenetics in anxiety disorders.表观遗传学在焦虑障碍中的作用。
Mol Biol Rep. 2023 Nov;50(11):9625-9636. doi: 10.1007/s11033-023-08787-6. Epub 2023 Oct 7.
6
The Role of Pharmacogenetics in Personalizing the Antidepressant and Anxiolytic Therapy.《药理学遗传学在个体化抗抑郁和抗焦虑治疗中的作用》。
Genes (Basel). 2023 May 16;14(5):1095. doi: 10.3390/genes14051095.
7
MAPK Is a Mutual Pathway Targeted by Anxiety-Related miRNAs, and E2F5 Is a Putative Target for Anxiolytic miRNAs.MAPK 是焦虑相关 miRNA 的共同作用途径，E2F5 是抗焦虑 miRNA 的潜在靶点。
Biomolecules. 2023 Mar 16;13(3):544. doi: 10.3390/biom13030544.
8
Epigenetics of Fear, Anxiety and Stress - Focus on Histone Modifications.恐惧、焦虑和压力的表观遗传学 - 关注组蛋白修饰。
Curr Neuropharmacol. 2024;22(5):843-865. doi: 10.2174/1570159X21666230322154158.
9
Alleviating anxiety and taming trauma: Novel pharmacotherapeutics for anxiety disorders and posttraumatic stress disorder.缓解焦虑和驯服创伤：焦虑障碍和创伤后应激障碍的新型药物治疗。
Neuropharmacology. 2023 Mar 15;226:109418. doi: 10.1016/j.neuropharm.2023.109418. Epub 2023 Jan 6.
10
Dark DNA and stress (Review).暗 DNA 与应激（综述）。
Int J Mol Med. 2023 Jan;51(1). doi: 10.3892/ijmm.2022.5211. Epub 2022 Dec 9.
本文引用的文献
1
Relation of Promoter Methylation of the Oxytocin Gene to Stressful Life Events and Depression Severity.催产素基因启动子甲基化与应激性生活事件和抑郁严重程度的关系。
J Mol Neurosci. 2020 Feb;70(2):201-211. doi: 10.1007/s12031-019-01446-1. Epub 2019 Nov 25.
2
Epigenetic Mechanisms of the Glucocorticoid Receptor.糖皮质激素受体的表观遗传机制。
Trends Endocrinol Metab. 2019 Nov;30(11):807-818. doi: 10.1016/j.tem.2019.07.003.
3
Transposable Elements.转座元件
Curr Top Behav Neurosci. 2019;42:221-246. doi: 10.1007/7854_2019_112.
4
Prenatal Dexamethasone Exposure Induced Alterations in Neurobehavior and Hippocampal Glutamatergic System Balance in Female Rat Offspring.产前地塞米松暴露导致雌性大鼠后代神经行为及海马谷氨酸能系统平衡改变。
Toxicol Sci. 2019 Oct 1;171(2):369-384. doi: 10.1093/toxsci/kfz163.
5
Role of MicroRNAs in Anxiety and Anxiety-Related Disorders.微小RNA在焦虑及焦虑相关障碍中的作用
Curr Top Behav Neurosci. 2019;42:185-219. doi: 10.1007/7854_2019_109.
6
A longitudinal study of the associations of BDNF genotype and methylation with poststroke anxiety.一项关于 BDNF 基因型和甲基化与卒中后焦虑相关性的纵向研究。
Int J Geriatr Psychiatry. 2019 Nov;34(11):1706-1714. doi: 10.1002/gps.5185. Epub 2019 Aug 7.
7
Exposure to workplace bullying, microRNAs and pain; evidence of a moderating effect of miR-30c rs928508 and miR-223 rs3848900.工作场所欺凌、microRNAs 和疼痛的暴露；miR-30c rs928508 和 miR-223 rs3848900 调节作用的证据。
Stress. 2020 Jan;23(1):77-86. doi: 10.1080/10253890.2019.1642320. Epub 2019 Jul 24.
8
Histone deacetylases inhibitor trichostatin A reverses anxiety-like symptoms and memory impairments induced by maternal binge alcohol drinking in mice.组蛋白去乙酰化酶抑制剂曲古抑菌素 A 可逆转母鼠 binge 饮酒诱导的小鼠焦虑样症状和记忆损伤。
J Psychopharmacol. 2019 Dec;33(12):1573-1587. doi: 10.1177/0269881119857208. Epub 2019 Jul 11.
9
Mechanism of Action for HDAC Inhibitors-Insights from Omics Approaches.组蛋白去乙酰化酶抑制剂的作用机制——组学方法的见解。
Int J Mol Sci. 2019 Apr 1;20(7):1616. doi: 10.3390/ijms20071616.
10
Social isolation and social support at adulthood affect epigenetic mechanisms, brain-derived neurotrophic factor levels and behavior of chronically stressed rats.成年期的社交隔离和社会支持会影响表观遗传机制、脑源性神经营养因子水平以及慢性应激大鼠的行为。
Behav Brain Res. 2019 Jul 2;366:36-44. doi: 10.1016/j.bbr.2019.03.025. Epub 2019 Mar 14.
Zotero 插件